Related Experiment Video

Updated: Jul 5, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

Antinuclear antibodies in children with epilepsy treated by carbamazepine

Ali Akbar Asadi-Pooya1, Kamiar Asadi-Pooya

  • 1Shiraz University of Medical Sciences, Shiraz, Iran. aliasadipooya@yahoo.com

Epilepsy Research
|May 21, 2008
PubMed

Insights

The prevalence of antinuclear antibodies (ANAs) in children with epilepsy on carbamazepine monotherapy is very low. This finding suggests that routine ANA screening is not necessary for these pediatric patients.

Area of Science:

  • Pediatric Neurology
  • Rheumatology
  • Clinical Immunology

Background:

  • Antinuclear antibodies (ANAs) have been linked to an increased prevalence in epilepsy patients.
  • Carbamazepine is a common antiepileptic drug used in monotherapy for children.

Purpose of the Study:

  • To investigate the prevalence of ANAs in pediatric patients with epilepsy receiving carbamazepine monotherapy.
  • To assess the clinical significance of ANA positivity in this specific patient group.

Main Methods:

  • An observational, descriptive study was conducted.
  • 58 children (ages 3-18) with epilepsy on carbamazepine monotherapy were enrolled.
  • Blood samples were analyzed for ANA presence and characteristics.

Main Results:

  • Only one out of 58 patients (1.7%) tested positive for ANA.
  • The positive ANA case showed a speckled pattern at a 1:80 dilution.
  • The vast majority of patients on carbamazepine monotherapy had negative ANA results.

Conclusions:

  • The prevalence of ANA in children with epilepsy treated with carbamazepine monotherapy is not significant.
  • The low rate of positive ANA in this cohort appears to have no clinical implications.
  • Routine ANA monitoring may not be required for pediatric epilepsy patients on carbamazepine unless specific clinical indications arise.
Abstract

More Related Videos

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy10:22

Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy

Published on: December 6, 2016

Related Concept Videos

Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...